|
TELO Telomir Pharmaceuticals Inc 1971532 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-1,721,528.00 |
| Balance Sheet |
|
Current Assets
|
$5,365,904.00 |
|
Assets
|
$5,365,904.00 |
|
Current Liabilities
|
$332,424.00 |
|
Liabilities
|
$332,424.00 |
|
Equity
|
$5,033,480.00 |
|
Shares Out
|
68774956.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,785,842.00 |
| Market Analysis |
Market Cap
|
$77,715,700.28 |
|
Price
|
$1.13 |
|
BVPS
|
0.07 |
|
PB
|
16.14 |
|
EPS
|
-0.79 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:51 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:42 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TELO documents filed with the SEC.
TELO Filings
Clear
